ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3014

Endotrophin: A Novel Adipokine Linking Adipose Tissue and Skin Fibrosis in Systemic Sclerosis

Roberta Goncalves Marangoni1, Jun Wei2, Monique E. Hinchcliff1, Philipp E. Scherer3 and John Varga2, 1Division of Rheumatology, Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 3University of Texas Southwestern Medical Center, Dallas, TX

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adipokines, fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Adipocytes and their progenitor cells are embedded in a network of extracellular matrix that plays a role in regulating its function. Type 6 collagen (COL6) is the most highly expressed collagen in differentiated adipocytes and its expression is upregulated in the skin in systemic sclerosis (SSc). The cleavage product of COL6α3, endotrophin, is secreted by mature adipocytes. The recently described adipokine, endotrophin, exerts a major influence locally in adipose tissue and has potential effects on triggering fibrosis and inflammation in both metabolic dysfunction and in growing solid tumors. In SSc, recent findings point to an unrecognized connection between adipose tissue, adipokines, and fibrosis. We, therefore, hypothesize that in SSc abnormal endotrophin expression contributes to dermal fibrosis.

Methods: To examine COL6 expression in SSc skin, we first queried a publicly available data set comprising genome-wide expression data from SSc and healthy control skin biopsy samples. COL6 mRNA expression was also examined in explanted fibroblasts from SSc skin biopsies and healthy controls. Tissue levels of endotrophin protein in skin biopsy samples from SSc patients with diffuse subtype and healthy controls were examined by immunohistochemistry.

Results: Levels of COL6 mRNA were found to be significantly increased (p < 0.001) in skin biopsy samples mapping to the diffuse-proliferative and inflammatory intrinsic subsets compared to normal-like subsets. Expression levels of COL6α3 mRNA were positively correlated with the total skin score (MRSS) (R=0.39, p<0.001). Elevated COL6 mRNA expression in SSc skin biopsy samples was confirmed by real-time qPCR (p=0.02). Endotrophin was markedly increased in both dermis and intradermal adipose tissue of diffuse SSc patients as compared to healthy controls (p=0.002).

Conclusion: Endotrophin and COL6 expression are both highly expressed in the skin in SSc. Endotrophin has potential effects on fibrosis in SSc and might be a potential target of therapy.


Disclosure: R. G. Marangoni, None; J. Wei, None; M. E. Hinchcliff, None; P. E. Scherer, None; J. Varga, None.

To cite this abstract in AMA style:

Marangoni RG, Wei J, Hinchcliff ME, Scherer PE, Varga J. Endotrophin: A Novel Adipokine Linking Adipose Tissue and Skin Fibrosis in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/endotrophin-a-novel-adipokine-linking-adipose-tissue-and-skin-fibrosis-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endotrophin-a-novel-adipokine-linking-adipose-tissue-and-skin-fibrosis-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology